Ether–lipid (alkyl-phospholipid) metabolism and the mechanism of action of ether–lipid analogues in Leishmania
- 30 November 2000
- journal article
- Published by Elsevier in Molecular and Biochemical Parasitology
- Vol. 111 (1) , 1-14
- https://doi.org/10.1016/s0166-6851(00)00278-4
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Topical treatment with hexadecylphosphocholine (Miltex®) efficiently reduces parasite burden in experimental cutaneous leishmaniasisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1999
- Efficacy of anticancer alkylphosphocholines in Trypanosoma brucei subspeciesActa Tropica, 1997
- The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma bruceiJournal of Antimicrobial Chemotherapy, 1996
- Antileishmanial activity of the ether phospholipid ilmofosineTransactions of the Royal Society of Tropical Medicine and Hygiene, 1993
- Alkylphosphocholines: a new class of membrane-active anticancer agentsCancer Chemotherapy and Pharmacology, 1993
- Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in miceAntimicrobial Agents and Chemotherapy, 1992
- Metabolism of ether lysophospholipids in Leishmania donovani promastigotesMolecular and Biochemical Parasitology, 1987
- Clinical phase I pilot study of the alkyl lysophospholipid derivative ET‐18‐OCH3Lipids, 1987
- The activity of alkyl phosphorylcholines and related derivatives against Leishmania donovaniBiochemical Pharmacology, 1987
- Cytotoxicity of ester and ether lysophospholipids on Leishmania donovani promastigotesMolecular and Biochemical Parasitology, 1987